Evidence map›Paper›PMID 27283515›Full record

ReviewTrends in biochemical sciences2016

The APOBEC Protein Family: United by Structure, Divergent in Function.

Jason D Salter, Ryan P Bennett, Harold C Smith

Open access · greenAbstract readReview
In one paragraph

Review in Trends in biochemical sciences, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 264 papers.

0numbers the graph read from it
0cells of the map it votes in
264citing papers in PubMed
16.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

264 citing papers in PubMed, 416 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Journal of virology · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. An ADAR2-mimic base editor for efficient C-to-U RNA editing in vivo.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article

204 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Jason D SalterOyaGen, Inc., 77 Ridgeland Road, Rochester, NY 14623, USA.
Ryan P BennettOyaGen, Inc., 77 Ridgeland Road, Rochester, NY 14623, USA.
Harold C SmithOyaGen, Inc., 77 Ridgeland Road, Rochester, NY 14623, USA; University of Rochester, School of Medicine and Dentistry, Department of Biochemistry and Biophysics, 601 Elmwood Avenue, Rochester, NY 14642, USA. Electronic address: harold.smith@rochester.edu.
OyaGen (United States) · US

Funding

Discovery of Chemical Probes for RNA-Binding Protein Host Defense FactorsR01GM110119 · NIGMS · OYAGEN, INC. · PI SMITH, HAROLD C · 2015 to 2017
$1.8M
Identification of Antagonists of the Molecular Chaperone Function of CBF betaR01GM110568 · NIGMS · OYAGEN, INC. · PI SMITH, HAROLD C · 2013 to 2015
$1.4M
NIGMS NIH HHS R01 GM110119NIGMS NIH HHS R01 GM110568
6 · The paper itself

Abstract

The APOBEC (apolipoprotein B mRNA editing catalytic polypeptide-like) family of proteins have diverse and important functions in human health and disease. These proteins have an intrinsic ability to bind to both RNA and single-stranded (ss) DNA. Both function and tissue-specific expression varies widely for each APOBEC protein. We are beginning to understand that the activity of APOBEC proteins is regulated through genetic alterations, changes in their transcription and mRNA processing, and through their interactions with other macromolecules in the cell. Loss of cellular control of APOBEC activities leads to DNA hypermutation and promiscuous RNA editing associated with the development of cancer or viral drug resistance, underscoring the importance of understanding how APOBEC proteins are regulated.

Indexed as

APOBEC DeaminasesHumansAPOBEC DeaminasesAPOBECcytidine deaminasedisease mechanismsDNA mutationepigeneticsRNA editing

Identifiers

PMID27283515
PMCPMC4930407
OpenAlexW2410097241

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.